Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RBP4 | P02753 | 1/20 | 0.40 |
| ▸ | RBBP9 | O75884 | 1/20 | 0.36 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.36 |
| ▸ | SMO | Q99835 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 3/20 | 0.34 |
| ▸ | MGLL | Q99685 | 6/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL693819 | 0.78 | MGLL (0.50) | RBP4SMOMGLL | |
| Hydrochloric Acid SCHEMBL14813360 | 0.77 | MGLL (0.49) | RBP4SMOMGLL | |
| SCHEMBL584468 | 0.76 | CHRNA4 (0.55) | — | |
| SCHEMBL2721136 | 0.75 | RBP4 (0.51) | ALDH1A1RBP4SMOMGLL | |
| SCHEMBL30359120 | 0.75 | TRPV4 (0.42) | ALDH1A1TRPV4 | |
| SCHEMBL7723818 | 0.74 | ALDH1A1 (0.38) | ALDH1A1RBP4RBBP9MGLL | |
| SCHEMBL30359028 | 0.74 | TRPV4 (0.41) | ALDH1A1TRPV4MGLL | |
| SCHEMBL584771 | 0.74 | CHRNA4 (0.57) | — | |
| SCHEMBL2130529 | 0.71 | CYP3A4 (0.46) | ALDH1A1RBP4SMOMGLLHKDC1 | |
| SCHEMBL2130521 | 0.71 | CYP3A4 (0.46) | ALDH1A1RBP4SMOMGLLHKDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116057057-A | Conjugates of alpha 2-adrenoceptor subtype C (alpha-2C) antagonists and TASK1/3 channel blockers for the treatment of sleep apnea | 拜耳公司 | 2023-05-02 | — | — | CN | disclosed |